Expert at Cincinnati Children's discusses how new pediatric-specific stents offer less invasive, adaptable treatment options ...

More than 80 local middle and high school students connected with Cincinnati Children's researchers and health professionals ...

For people living with eosinophilic gastritis (EoG), keeping track of disease activity often requires repeated endoscopies and tissue biopsies. While these procedures provide valuable information, ...

The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, ...

The Research Horizons blog features news and insights about the latest discoveries and innovations developed by the scientists of Cincinnati Children's. This blog does not provide medical advice, ...

Go ahead, crack a joke. Butt seriously, this research from an expert at Cincinnati Children’s and the Tokyo Medical and Dental University might save lives someday by helping people when they cannot ...

The technique sounds so outlandish that it won an IgNobel prize in 2024. But the science behind rescuing people with blocked airways and clogged lungs by rectally delivering oxygen to the body is no ...

NBC’s Vicky Nguyen recently visited Cincinnati Children’s to interview experts here about their ongoing research to document how spending hours viewing smartphones, tablets and other device screens ...

A new clinical support tool called Anatool aims to provide point-of-care guidance to help healthcare professionals more consistently recognize and treat anaphylaxis, a severe and potentially ...

The Baltimore-based biotech company Elixirgen Therapeutics, Inc., has reported positive results from the first two patients to receive the company’s novel treatment for telomere biology disorders.

Extremely preterm newborns represent one of the miracles of modern medical science. The tiniest infant to survive the ordeal was born in San Diego in 2018 at just over 23 weeks gestational age and ...

Agreement calls for Cincinnati Children’s to work with New Zealand-based BioOra to test Alta-cel as treatment for relapsed or refractory B-ALL. Many adults with cancer are alive and thriving after ...